A Bloomberg report says German pharmaceutical company Boehringer Ingelheim GmbH is now facing more than 150 lawsuits over claims that the company sold the blood thinner Pradaxa despite being aware that it could cause potentially deadly bleeding.
Plaintiffs’ lawyers say the company will probably end up facing thousands more lawsuits in coming years. According to the story, the drug has been linked to ...
continue reading...In an analysis piece for Forbes, journalist Ed Silverman writes that the U.S. Food and Drug Administration may have used a flawed statistical model in its evaluation of the bleeding risks for the drug Pradaxa.
Pradaxa is a blood thinner, used to prevent blood clots and strokes in patients with atrial fibrillation. The Institute for Safe Medicine Practices has linked the drug to more than 500 deaths and ...
continue reading...Patients who go on low-dose daily aspirin appear to be at lower risk of developing potentially deadly blood clots, according to a story in U.S. News and World Report.
The story concerns a study in which researchers combined the results of a small study with those of a similar trial, so that the combined data was large enough to test for trends. The combined study indicated that daily aspirin could ...
continue reading...According to Reuters, the U.S. Food and Drug Administration has set March 17 as the deadline for deciding whether to approve blood thinner Eliquis for patients with atrial fibrillation.
The agency declined to approve the drug in June, requesting that manufacturers Bristol-Myers Squibb Co and Pfizer Inc. provide more information on a pivotal clinical trial of the medicine, which is designed to reduce the risk of stroke caused by blood ...
continue reading...New research indicates that people who stop taking the blood thinner warfarin over concerns about gastrointestinal bleeding raise their risk of blood clots and death if they remain off the drug, according to U.S. News and World Report.
Warfarin makes it harder for clots to form and block the blood stream, and is prescribed to ward off conditions such as stroke that are caused by blood clots. It also raises ...
continue reading...A report in USA Today concerns the legal action by hundreds of plaintiffs who used the blood-thinner Pradaxa, stating that it may amount to “the country’s next blockbuster civil settlement.”
The U.S. Food and Drug Administration approved Pradaxa, manufactured by German pharmaceutical giant Boehringer Ingelheim, in 2010. At the time, it was promoted as the first replacement for the commonly used blood thinner warfarin, known by the brand ...
continue reading...
